FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More »

Microsoft vulnerabilities report offers key cybersecurity insights

BeyondTrust, a privileged access management security technology vendor, today has released its “2021 Microsoft Vulnerabilities Report.“ The annual research includes the latest breakdown of Microsoft vulnerabilities by category and product, as well as a five-year trend analysis. These provide a holistic understanding of the evolving threat landscape. The report analyzes the data from security bulletins publicly issued… Read More »

“Hope Springs Eternal” With the COVID Vaccine for Both Joe Biden and Most People in the U.S.

More Americans are happier in March 2021 than they’ve been for a year, based on consumer research from Civic Science polling U.S. adults in early March 2021. For the first time, a larger percent of Americans said they were better off financially since the start of the pandemic. This week, Civic Science shared their latest data… Read More »

  1. Pages:
  3. 1
  4. ...
  5. 154
  6. 155
  7. 156
  8. 157
  9. 158
  10. 159
  11. 160
  12. ...
  13. 1458